IL165839A0 - Compounds useful for the treatment of cancer compositions thereof and methods therewith - Google Patents
Compounds useful for the treatment of cancer compositions thereof and methods therewithInfo
- Publication number
- IL165839A0 IL165839A0 IL16583903A IL16583903A IL165839A0 IL 165839 A0 IL165839 A0 IL 165839A0 IL 16583903 A IL16583903 A IL 16583903A IL 16583903 A IL16583903 A IL 16583903A IL 165839 A0 IL165839 A0 IL 165839A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- compounds useful
- cancer compositions
- methods therewith
- therewith
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38946102P | 2002-06-17 | 2002-06-17 | |
| US10/463,009 US7037936B2 (en) | 2002-06-17 | 2003-06-16 | Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
| PCT/US2003/018905 WO2003105774A2 (en) | 2002-06-17 | 2003-06-17 | Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL165839A0 true IL165839A0 (en) | 2006-01-15 |
Family
ID=29740147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16583903A IL165839A0 (en) | 2002-06-17 | 2003-06-17 | Compounds useful for the treatment of cancer compositions thereof and methods therewith |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7037936B2 (https=) |
| EP (1) | EP1551388A4 (https=) |
| JP (1) | JP2006515560A (https=) |
| CN (1) | CN1674888A (https=) |
| AU (1) | AU2003243587B2 (https=) |
| CA (1) | CA2488891A1 (https=) |
| IL (1) | IL165839A0 (https=) |
| MX (1) | MXPA04012675A (https=) |
| NZ (1) | NZ537653A (https=) |
| WO (1) | WO2003105774A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050100529A1 (en) * | 2003-11-06 | 2005-05-12 | Zeldis Jerome B. | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders |
| US8175808B2 (en) * | 2005-04-01 | 2012-05-08 | Sloan Kettering Institute For Cancer Research | Method for determining disease treatment duration |
| EP1957507B1 (en) | 2005-12-02 | 2018-10-24 | Ionis Pharmaceuticals, Inc. | Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents |
| WO2010030690A1 (en) | 2008-09-10 | 2010-03-18 | Isis Pharmaceuticals, Inc. | Antibacterial 4,6-substituted 6', 6" and 1 modified aminoglycoside analogs |
| WO2010030704A2 (en) | 2008-09-10 | 2010-03-18 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2010042850A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2010042851A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| EP2486044A2 (en) | 2009-10-09 | 2012-08-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| US9200008B2 (en) | 2010-07-02 | 2015-12-01 | Aska Pharmaceutical Co., Ltd. | Heterocyclic compound and p27Kip1 degradation inhibitor |
| CN103282370A (zh) | 2010-11-17 | 2013-09-04 | 尔察祯有限公司 | 抗菌氨基糖苷类类似物 |
| WO2012075232A1 (en) * | 2010-12-04 | 2012-06-07 | Trevena, Inc. | Opioid receptor ligands and methods of using and making the same |
| JP2024523237A (ja) | 2021-06-18 | 2024-06-28 | ホンジーン バイオテック コーポレイション | 官能化されたｎ－アセチルガラクトサミンヌクレオシド |
| JP2024532271A (ja) | 2021-08-30 | 2024-09-05 | ホンジーン バイオテック コーポレイション | 官能化ｎ－アセチルガラクトサミンアナログ |
| WO2023114746A1 (en) | 2021-12-15 | 2023-06-22 | Hongene Biotech Corporation | Functionalized n-acetylgalactosamine analogs |
| WO2024118503A1 (en) | 2022-11-28 | 2024-06-06 | Hongene Biotech Corporation | Functionalized n-acetylgalactosamine analogs |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3328249A (en) * | 1965-06-21 | 1967-06-27 | Sterling Drug Inc | Process for counteracting depressive states |
| US3485873A (en) * | 1966-12-21 | 1969-12-23 | Sterling Drug Inc | N-benzyl-n-methyl-omega-phenyl-omega-cycloalkyl-lower-alkylamines |
| GB9201755D0 (en) | 1992-01-28 | 1992-03-11 | British Bio Technology | Compounds |
| AU767507B2 (en) | 1998-08-28 | 2003-11-13 | New York University | Novel ubiquitin ligases as therapeutic targets |
| ES2361660T3 (es) | 1998-12-10 | 2011-06-21 | Signal Pharmaceuticals Llc | Ubicutina-ligasa e3 humana para la modulación de nk-kappa b. |
| US20010044445A1 (en) * | 1999-04-08 | 2001-11-22 | Bamaung Nwe Y. | Azole inhibitors of cytokine production |
| NZ527047A (en) | 2001-01-05 | 2006-09-29 | Univ New York | Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| WO2003101983A1 (en) * | 2002-05-31 | 2003-12-11 | Yamanouchi Pharmaceutical Co., Ltd. | Tetrahydropyran derivative |
-
2003
- 2003-06-16 US US10/463,009 patent/US7037936B2/en not_active Expired - Fee Related
- 2003-06-17 NZ NZ537653A patent/NZ537653A/en unknown
- 2003-06-17 CA CA002488891A patent/CA2488891A1/en not_active Abandoned
- 2003-06-17 AU AU2003243587A patent/AU2003243587B2/en not_active Ceased
- 2003-06-17 MX MXPA04012675A patent/MXPA04012675A/es active IP Right Grant
- 2003-06-17 CN CNA038193191A patent/CN1674888A/zh active Pending
- 2003-06-17 IL IL16583903A patent/IL165839A0/xx unknown
- 2003-06-17 EP EP03760389A patent/EP1551388A4/en not_active Withdrawn
- 2003-06-17 WO PCT/US2003/018905 patent/WO2003105774A2/en not_active Ceased
- 2003-06-17 JP JP2004512682A patent/JP2006515560A/ja active Pending
-
2006
- 2006-02-17 US US11/357,774 patent/US20060142352A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060142352A1 (en) | 2006-06-29 |
| CA2488891A1 (en) | 2003-12-24 |
| AU2003243587A1 (en) | 2003-12-31 |
| WO2003105774A2 (en) | 2003-12-24 |
| US20060030617A1 (en) | 2006-02-09 |
| US7037936B2 (en) | 2006-05-02 |
| AU2003243587B2 (en) | 2008-02-28 |
| JP2006515560A (ja) | 2006-06-01 |
| CN1674888A (zh) | 2005-09-28 |
| EP1551388A4 (en) | 2009-07-15 |
| EP1551388A2 (en) | 2005-07-13 |
| MXPA04012675A (es) | 2005-08-15 |
| WO2003105774A3 (en) | 2004-08-12 |
| NZ537653A (en) | 2007-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL375532A1 (en) | Benzimidazol-1-yl-thiophene compounds for the treatment of cancer | |
| AU6147401A (en) | Compositions and methods for the treatment of cancer | |
| WO2004030615A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| EP1571968A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2004016225A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2004045516A9 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| EP1628530B8 (en) | Methods and compositions for the prevention and treatment of sepsis | |
| AU2003230750A1 (en) | Compositions and methods for treating cancer | |
| IL165950A0 (en) | Compositions and method for the diagnosis and treatment of tumor | |
| EP1572091A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2004060270A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2003057160A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
| AU2003225535A1 (en) | Methods and compositions for treating cancer | |
| IL165839A0 (en) | Compounds useful for the treatment of cancer compositions thereof and methods therewith | |
| ZA200510282B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| IL145397A0 (en) | Compositions and methods for treatment of cancer | |
| AU2003237792A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| AU2003219160A1 (en) | Methods and compositions for the treatment of cancer | |
| PL368035A1 (en) | Compositions and methods for the treatment of cancer | |
| AU2003223538A1 (en) | Methods for the treatment of cancer | |
| HUP0500199A3 (en) | Pharmaceutical composition comprising arsenite for the treatment of malignancy | |
| AU2003220026A1 (en) | Methods and compositions for the treatment of ischemia | |
| AU2003270202A8 (en) | Pharmaceutical compositions useful for the treatment of cancers | |
| AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer |